Edimer Pharmaceuticals
http://edimerpharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Edimer Pharmaceuticals
Pierre Fabre Launches Pivotal Trial Of Pioneering Prenatal Therapy
The first boy suffering from X-linked hypohidrotic ectodermal dysplasia has been injected with a protein replacement therapy developed by the French firm and the Esperare Foundation while inside his mother's womb.
EspeRare CEO: Proceeds From Dermelix Co-Development Pact To Fund Genetic Pre-Natal Pipeline R&D
The CEO of Swiss not-for-profit foundation EspeRare tells Scrip how she will use funds generated from a co-development pact with Dermelix Biotherapeutics to create novel in utero treatments for rare genetic diseases.
Venture Funding Deals, January 2015
Derived from Strategic Transactions, a premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2014.
Start-Up Execs On The Move, October 2013
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice